CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 33 filers reported holding CATALYST BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,561 | +31.3% | 46,778 | -4.3% | 0.00% | – |
| Q2 2023 | $17,185 | +28.1% | 48,878 | -24.6% | 0.00% | – |
| Q1 2023 | $13,413 | +9.8% | 64,799 | +179.7% | 0.00% | – |
| Q4 2022 | $12,220 | -49.1% | 23,166 | -52.3% | 0.00% | – |
| Q3 2022 | $24,000 | -14.3% | 48,560 | +646.2% | 0.00% | – |
| Q2 2021 | $28,000 | – | 6,508 | +17977.8% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 36 | -99.6% | 0.00% | – |
| Q2 2020 | $55,000 | +77.4% | 9,368 | +32.0% | 0.00% | – |
| Q1 2020 | $31,000 | +416.7% | 7,095 | +688.3% | 0.00% | – |
| Q4 2019 | $6,000 | +100.0% | 900 | +28.6% | 0.00% | – |
| Q3 2019 | $3,000 | -66.7% | 700 | -17.6% | 0.00% | – |
| Q3 2018 | $9,000 | -71.0% | 849 | -30.1% | 0.00% | – |
| Q1 2018 | $31,000 | – | 1,215 | +20150.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 6 | -98.7% | 0.00% | – |
| Q2 2017 | $2,000 | – | 458 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |